Tag: RSV

Industry Focus Areas, Medical

Moderna Cuts Outlook Amid Covid-Vaccine Supply Hurdles

November 3, 2022

Via: The Wall Street Journal

Moderna Inc.’s third-quarter revenue fell by nearly a third and the pharmaceutical company cut its outlook, saying as part of its earnings report that supply constraints for its Covid-19 vaccines might sap as much as $3 billion in sales this […]